Trade JnJ JNJ

Sell
 Buy

JnJ live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

JnJ News

Frances Wang 2026 Feb 02, 16:00

Why is Palantir stock rising: What will Palantir (PLTR) be worth in 2030?

Ghko B 2026 Feb 02, 16:00

Bitcoin prices fall below $79K: How low BTC/USD can go in 2026?

Frances Wang 2026 Feb 02, 16:00

FTSE 100 hits record high: What's driving the FTSE 100 past 10,340?

Ghko B 2026 Feb 02, 16:00

Gold price prediction: Will gold (XAU/USD) reach $6,000 anytime soon?

Ghko B 2026 Feb 01, 16:00

ETF trading for beginners: What’s the best S&P 500 ETF to invest in 2026?

Ghko B 2026 Feb 01, 16:00

Solana price forecast: What will Solana (SOL/USD) be worth in 5 years?

Ghko B 2026 Feb 01, 16:00

Microsoft stock price prediction 2026: What is the target price for MSFT?

Frances Wang 2026 Feb 01, 16:00

Trending AI stock analysis: Why Sandisk (SNDK) stock continues to rise?

Frances Wang 2026 Feb 01, 16:00

XRP (Ripple) Price Prediction: How High Will XRP/USD Price Go In 2026?

Frances Wang 2026 Jan 29, 16:00

Big tech stock analysis: Meta stocks jumped 10%, what’s going on with Meta?

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

1.42

Spread (%)

0.6110 %

Leverage

1:2

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

555944837120

Shares Outstanding

2409295102

Earnings Date (Next)

2001-06-13

Div Yield

2026-03-10

Ex-Dividend Date

2026-02-24

Forward annual dividend rate

5.2

Forward annual dividend yield

0.0225

EPS

11.03

Learn more about this instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Georgy Istigechev 2026 Feb 02, 16:00

CFD Trading for Beginners: What to Know about Online Markets & Trading Platforms?

Ghko B 2026 Jan 29, 16:00

CFD trading basics: Long position VS. short position, which is better?

Ghko B 2026 Jan 27, 16:00

What is a stochastic indicator: How to read the stochastic indicator?

Trustpilot